AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2023
Dec 30, 2023
32044_dirs_2023-12-29_06493f48-db12-4e39-903a-2cc9b218b2a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2023-12-28
Reporting Person: KINDLER JEFFREY B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-28 | Common Stock | S | 96686 | $1.41 | Disposed | 238275 | Direct |
Footnotes
F1: On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23